<DOC>
	<DOCNO>NCT00643292</DOCNO>
	<brief_summary>A phase 3 randomize , multicenter , double blind , double dummy study ass efficacy , safety , compliance single dose azithromycin extend release compare 10-day course amoxicillin/clavulanate twice daily child high risk persistent recurrent ear infection</brief_summary>
	<brief_title>A Single , High-Dose Azithromycin Extended Release ( 60 mg/kg ) Compared With 10 Days High-Dose Amoxicillin Clavulanate Children With Ear Infections High Risk Persistent/Recurrent Ear Infections</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Outpatients clinical evidence acute otitis medium weigh least 5 kg include Patients previously diagnose disease immune function , treatment systemic antibiotic within previous 7 day , cleft lip/palate anatomic abnormality predispose otitis medium exclude .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>48 Months</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>